You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous G-CSF mobilized HSCs

Showing 1 - 25 of 8,259
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Beijing (Plerixafor,G-CSF)

Not yet recruiting
  • Lymphoma
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
Aug 19, 2022

Intermittent Claudication, PAD, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No PB-MNC therapy)

Recruiting
  • Intermittent Claudication
  • +2 more
  • PB-MNC therapy
  • No PB-MNC therapy
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital, Mahidol University
Dec 16, 2021

PAD, Critical Limb Ischemia, Atherosclerotic Ischemic Disease Trial in Bangkoknoi (PB-MNC therapy, No-PB-MNC therapy)

Recruiting
  • PAD
  • +2 more
  • PB-MNC therapy
  • No-PB-MNC therapy
  • Bangkoknoi, Bangkok, Thailand
    Vascular Surgery, Siriraj Hospital, Mahidol University
Dec 16, 2021

Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,

Recruiting
  • Severe Aplastic Anemia
  • MDS (Myelodysplastic Syndrome)
  • Miltenyi CD34 Reagent System
  • Donor derived G-CSF mobilized PBC
  • Baltimore, Maryland
  • +2 more
Jan 25, 2023

Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected

No longer available
  • Chronic Myeloid Leukemia
  • +2 more
  • G-CSF mobilized CD34+ selected cells for transplantation
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Feb 28, 2022

Granulocyte Colony-stimulating Factor, Stem Cell Mobilization Trial (PEG-rhG-CSF)

Not yet recruiting
  • Granulocyte Colony-stimulating Factor
  • Stem Cell Mobilization
  • (no location specified)
Jun 13, 2022

Improved Methods of Cell Selection for Bone Marrow Transplant

Recruiting
  • Graft-Versus-Host Disease
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 23, 2023

Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)

Recruiting
  • Autologous Haematopoietic Stem Cell Transplant
  • plerixafor + G-CSF
  • China, China
    Investigational Sites
May 4, 2022

Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

Not yet recruiting
  • Granulocyte Colony-Stimulating Factor
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 31, 2023

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Multiple Myeloma Trial in Worldwide (BL-8040 1.25mg/kg + G-CSF, Placebo +G-CSF)

Active, not recruiting
  • Multiple Myeloma
  • BL-8040 1.25mg/kg + G-CSF
  • Placebo +G-CSF
  • Los Angeles, California
  • +17 more
Jun 14, 2022

Malignant Glioma, High Grade Glioma Trial in Birmingham, Washington, Gainesville (TTRNA-DC vaccines with GM-CSF,

Recruiting
  • Malignant Glioma
  • High Grade Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +4 more
  • Birmingham, Alabama
  • +2 more
Feb 2, 2023

Dilated Cardiomyopathy Trial in London (Bone marrow derived mononuclear cells and G-CSF)

Recruiting
  • Dilated Cardiomyopathy
  • Bone marrow derived mononuclear cells and G-CSF
  • London, United Kingdom
    St Bartholomew's Hospital
Mar 21, 2022

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete

Completed
Has Results
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022

Non-Hodgkin Lymphoma, Hodgkin Lymphoma Trial in Minneapolis (drug, procedure, biological, radiation)

Recruiting
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 25, 2023

Multiple Myeloma, Relapsed, Multiple Myeloma, Refractory to Standard Treatment Trial in Chicago (radiation, drug, procedure)

Completed
  • Multiple Myeloma, Relapsed
  • Multiple Myeloma, Refractory to Standard Treatment
  • Total Marrow Irradiation
  • +3 more
  • Chicago, Illinois
    University of Illinois Cancer Center
Nov 20, 2021

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Neuroblastoma Trial in Minneapolis (drug, biological, radiation)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting
  • Diffuse Intrinsic Pontine Glioma (DIPG)
  • Brain Stem Glioma
  • TTRNA-DC vaccines with GM-CSF
  • +5 more
  • Gainesville, Florida
    UF Health Shands Children's Hospital
Apr 29, 2022

AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))

Terminated
  • AIDS-related Lymphoma
  • HIV Infections
  • PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Sep 4, 2022

Multiple Myeloma Trial in Tampa (biological, procedure, drug)

Active, not recruiting
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022